文献速递复苏、休克与脓毒症心脑血管急症

急诊医疗服务中的即时检验:范围综述

Point-of-care tests in the emergency medical services: a scoping review.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2025-02-03
一句话结论急诊医疗服务即时检验研究多集中于诊断准确性,随机对照试验、经济学评价与可接受性定性研究极少,从准确性研究到首个随机对照试验的延迟可达11年。

该范围综述检索三个数据库至2023年4月,纳入141篇论文,涵盖158项报告、9种研究设计、40种生物标志物与病症组合、41种检测设备。研究多数在英国(19%)、美国(17%)和荷兰(16%)完成,82%为陆基急诊医疗服务;最常评估的是肌钙蛋白用于急性冠脉综合征(26%)、乳酸用于脓毒症(14%)或乳酸用于创伤/危重症(13%)。多数研究设计为调查检测准确性(43%),随机对照试验仅4%、能评估因果关系的非随机研究6%、经济学分析1%、可接受性定性研究3%。在少数已完成的随机对照试验中,从初始检测准确性研究到首个随机对照试验发表存在长时间延迟,例如肌钙蛋白用于急性冠脉综合征延迟11年。作者认为需要投资资金和基础设施以支持即时检验研究路径超越诊断准确性,转向能评估临床有效性、可接受性和经济有效性的设计。

要点

  • 综述纳入141篇论文,涵盖158项报告、9种研究设计、40种生物标志物与病症组合、41种检测设备。
  • 研究多数在英国(19%)、美国(17%)和荷兰(16%),82%为陆基急诊医疗服务。
  • 最常评估:肌钙蛋白用于急性冠脉综合征(26%)、乳酸用于脓毒症(14%)、乳酸用于创伤/危重症(13%)。
  • 研究设计以检测准确性为主(43%),随机对照试验仅4%、能评估因果关系的非随机研究6%、经济学分析1%、可接受性定性研究3%。
  • 少数随机对照试验中,从初始检测准确性研究到首个随机对照试验发表延迟长,如肌钙蛋白用于急性冠脉综合征延迟11年。

适用人群与场景

  • 急诊医疗服务(EMS)场景,多数研究为陆基EMS(82%)。

研究设计与关键结果

  • 范围综述检索三个数据库至2023年4月,纳入141篇论文,包括158项报告、9种研究设计、155项报告涉及40种生物标志物与病症组合、161项报告涉及41种检测设备。
  • 研究多数在英国(19%)、美国(17%)和荷兰(16%),82%为陆基EMS。
  • 最常评估的是肌钙蛋白用于急性冠脉综合征(26%)、乳酸用于脓毒症(14%)或乳酸用于创伤/危重症(13%)。
  • 多数研究设计调查检测准确性(43%);随机对照试验占4%,能评估因果关系的非随机研究占6%,经济学分析占1%,可接受性定性研究占3%。
  • 在少数已完成的随机对照试验中,从初始检测准确性研究到首个随机对照试验发表存在长时间延迟,例如肌钙蛋白用于急性冠脉综合征延迟11年。

证据类型、等级与局限

  • 证据类型:范围综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需要投资资金和基础设施以支持即时检验的研究路径超越诊断准确性,转向能评估临床有效性、可接受性和经济有效性的设计。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This scoping review aimed to summarize existing research on point-of-care tests (POCTs) within emergency medical services (EMS). There is a lack of comprehensive reviews covering the breadth and scope of application of POCTs in EMS despite growing interest and potential benefits in this setting. A review of the research will inform how we target future research efforts to support effective implementation and avoid duplication.

METHODS: We searched three databases to April 2023 using comprehensive terms for POCTs. One author screened titles and abstracts, full-text papers and extracted data with a second author checking the data. A scoping review framework was used to categorise studies according to demographics, study design, medical conditions, biomarkers and test devices.

RESULTS: We found 141 papers that included 158 reports of 9 study designs, 155 reports of 40 combinations of biomarker and condition and 161 reports of 41 test-devices. The majority of research was done in the UK (19%), US (17%), and the Netherlands (16%), mostly in land-based EMS (82%). Most frequently assessed were troponin for acute coronary syndromes (26%), lactate for sepsis (14%) or lactate for trauma/critical illness (13%). The majority of research designs investigated the accuracy of the tests (43%). Few studies were of a design to inform guidelines to change patient pathways and the associated outcomes, including, randomised controlled trials (RCTs) (4%), non-randomised studies able to assess causality (6%), economic analyses (1%) or qualitative work on acceptability (3%). In those few cases where RCTs were done there were long delays between initial test-accuracy research and publication of the first RCT, for example 11 years delay for troponin for acute coronary syndromes.

CONCLUSIONS: We identified a thriving base of research on POCT in the EMS, however most studies established the diagnostic accuracy of the tests with few RCTs, economic analyses or qualitative research on acceptability. The time-lag from diagnostic accuracy to developing an RCT is considerable. Investment in funding and infrastructure is needed to support the research pathway for potential POCTs beyond diagnostic accuracy to designs able to assess clinical effectiveness, acceptability and economic effectiveness.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Moore THM, Dawson S, Kirby K, et al. Point-of-care tests in the emergency medical services: a scoping review. Scand J Trauma Resusc Emerg Med. 2025. PMID: 39901298. doi:10.1186/s13049-025-01329-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。